Par Pharmaceutical begins shipment of generic Atacand

Par Pharmaceutical (PRX) announced that it has entered into an exclusive U.S. supply and distribution agreement with AstraZeneca to distribute the authorized generic version of AstraZeneca's (AZN) Atacand. Par has begun shipping 4 mg, 8 mg, 16 mg and 32 mg strengths of candesartan cilexetil tablets. According to IMS Health data, annual U.S. sales of Atacand are approximately $113M.

View Comments (0)